Ahmad Ghorab - Dissemin

Language
Login

All papers authored by Ahmad Ghorab

This paper was not found in any repository, but could be made available legally by the author.

2024 Mohamed Abouzid, Ahmed Abdelhakeem

ORCID

, Shorouk Elshafie, Ahmad Ghorab

ORCID

Heyde’s syndrome: a challenging case of severe aortic stenosis and gastrointestinal bleeding

Upload

Distributing this paper is prohibited by the publisher

2023 Ahmad Ghorab

ORCID

, Firas Baidoun, Osama Mosalem, Karan Seegobin, Muhamad Alhaj Moustafa, Han Tun

Clinicopathologic Features and Survival Outcomes of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) of the Urothelial Organs (Urologic MALT Lymphoma): The Mayo Clinic Experience (2013-2022)

Upload

Distributing this paper is prohibited by the publisher

Ahmad Ghorab

ORCID

, Osama Mosalem, Firas Baidoun, Han Tun, Muhamad Alhaj Moustafa

Experience with Gray Zone Lymphoma (GZL) at Mayo Clinic: A Review of Clinical Characteristics and Treatment Outcomes

Upload

This paper was not found in any repository, but could be made available legally by the author.

Ahmad Ghorab

ORCID

, Mark Litzow, Naseema Gangat, Aref Al-Kali, Mithun Shah, Hemant Murthy, Hasan Alkhateeb, Kebede Begna, Mrinal Patnaik, James Foran, Talha Badar

AML-497 Salvage Treatment With Venetoclax (Ven) and Hypomethylating Agents (HMA) for Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (AML) Patients: Clinical Characteristics and Outcomes

Upload

This paper is made freely available by the publisher.

2022 Ahmad Ghorab

ORCID

, Mark R. Litzow, Naseema Gangat, Aref Al-Kali, Mithun V. Shah, Hemant S. Murthy, Ayalew Tefferi, Hassan B. Alkhateeb, Kebede Begna, Mrinal M. Patnaik, James M. Foran, Talha Badar

Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)

Download from ashpublications.org

This paper was not found in any repository, but could be made available legally by the author.

Ahmad Ghorab

ORCID

, Aref Al-Kali, Michelle Elliot, Naseema Gangat, Hasan Alkhateeb, Mithun Shah, Cecilia Arana Yi, Hemant Murthy, Mohamed Kharfan Dabaja, Ayalew Tefferi, Mrinal Patnaik, Mark Litzow, Talha Badar

MDS-353 Clinical Outcome of Myelodysplastic Syndrome Progressing on Hypomethylating Agents With Evolving Frontline Therapies: Continued Challenges and Unmet Needs

Upload

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

2021 Ahmad Ghorab

ORCID

, Aref Al-Kali, Michelle A. Elliot, Mithun V. Shah, Jeanne M. Palmer, Hemant S. Murthy, Mohamed A. Kharfan-Dabaja, Mark R. Litzow, James M. Foran, Talha Badar

Improved Clinical Outcome of Patients with Myelodysplastic Syndrome (MDS) Progressing after Hypomethylating Agent: In the Era of Novel Therapies

Download from ashpublications.org

This paper is made freely available by the publisher.

2020 Iman Abou Dalle

ORCID

, Ahmad Ghorab

ORCID

, Keyur Patel, Xuemei Wang, Hyunsoo Hwang, Jorge Cortes, Ghayas C. Issa

ORCID

, Fevzi Yalniz, Koji Sasaki, Dai Chihara

ORCID

, Allyson Price, Tapan Kadia, Naveen Pemmaraju, Naval Daver, Courtney DiNardo

ORCID

and 3 other authors

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia

Download from www.nature.com

Distributing this paper is prohibited by the publisher

2019 Preetesh Jain, Rashmi Kanagal-Shamanna, Chi Young Ok, Gonzalez-Pagan Omarya, Lucy Navsaria, F. B. Hagemeister, Hun Ju Lee, Graciela M. Nogueras González, Krystle Nomie, Changying Jiang, Shaojun Zhang, Luis Fayad, Jason R. Westin, Guangchun Han, Loretta J. Nastoupil and 16 other authors

Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma - Cohort Study of 369 Patients

Upload

This paper was not found in any repository, but could be made available legally by the author.

P. Jain, R. Kanagal-Shamanna, S. Zhang, C. Ok, G. Nogueras Gonzalez, O. Gonzalez-Pagan, K. Nomie, L. Fayad, A. Ghorab

ORCID

, J. Westin, P. Boddu, L. Nastoupil, K. Patel, W. Chen, S. Ahmed and 10 other authors

Comprehensive Analysis of Prognostic Factors, Outcomes and Mutation Profile in Patients With Aggressive Histology (Blastoid/Pleomorphic) or Transformed Mantle Cell Lymphoma

Upload

Distributing this paper is prohibited by the publisher

2018 Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, Graciela M. Nogueras González, Chi Young Ok, Makhdum Ahmed, Hun Ju Lee, Graciela M. Nogueras González, Gonzalez-Pagan Omarya, Maria Badillo, Krystle Nomie, Ahmad Ghorab

ORCID

, Luis Fayad, Prajwal C. Boddu, Loretta J. Nastoupil and 9 other authors

Clinical and Genomic Characteristics in De Novo Blastoid/Pleomorphic (dnMCL) and Transformed Blastoid/Pleomorphic (t-MCL) Mantle Cell Lymphoma (MCL) in the Ibrutinib Era: Comprehensive Analysis of 168 Patients

Upload

This paper is made freely available by the publisher.

Preetesh Jain

ORCID

, Rashmi Kanagal-Shamanna, Shaojun Zhang, Makhdum Ahmed, Ahmad Ghorab

ORCID

, Liang Zhang, Tiejun Gong, Chi Young Ok, Wendy Chen, Shaoying Li, Maria Badillo, Krystle Nomie, Frederick Hagemeister, Luis Fayad, Leonard J. Medeiros and 7 other authors

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

Download from api.wiley.com

This paper is made freely available by the publisher.

Ahmad Ghorab

ORCID

, Hagop M. Kantarjian, Preetesh Jain, Rashmi Kanagal-Shamanna, Elias Jabbour, Koji Sasaki, Tapan M. Kadia, Kiran Naqvi, Guillermo Garcia-Manero, William G. Wierda, Prithviraj Bose, Srdan Verstovsek, Nitin Jain, Musa Yilmaz, Zeev Estrov and 3 other authors

Concordant extra-medullary and bone marrow disease (EMD-BM) of blastic transformation of chronic myeloid leukemia (CML-BP) in the tyrosine kinase (TKI) era: Characteristics, treatments and outcomes.

Download from doi.org

This paper is made freely available by the publisher.

Tapan M. Kadia, Jorge E. Cortes, Ahmad Ghorab

ORCID

, Farhad Ravandi, Elias Jabbour, Naval Guastad Daver, Yesid Alvarado, Maro Ohanian, Marina Konopleva, Hagop M. Kantarjian

Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients.

Download from doi.org

This paper is made freely available by the publisher.

Ahmad Ghorab

ORCID

, Keyur Patel, Jorge E. Cortes, Dai Chihara, Allyson Price, Tapan M. Kadia, Farhad Ravandi, Naveen Pemmaraju, Naval Guastad Daver, Hagop M. Kantarjian, Courtney Denton Dinardo, Gautam Borthakur

Impact of numerical variation, allele burden and mutation length on outcomes in acute myeloid leukemia with fms-like tyrosine kinase receptor-3 internal tandem duplication (FLT3-ITD) mutation.

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 Preetesh Jain

ORCID

, Hagop M. Kantarjian, Ahmad Ghorab

ORCID

ORCID

, Elias J. Jabbour, Graciela Nogueras Gonzalez, Rashmi Kanagal‐Shamanna

ORCID

, Ghayas C. Issa, Guillermo Garcia‐Manero, Devendra Kc, Sara Dellasala, Sherry Pierce, Marina Konopleva, William G. Wierda, Srdan Verstovsek and 7 other authors

Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Preetesh Jain, Rashmi Kanagal-Shamanna, Hagop M. Kantarjian, F. Anthony San Lucas, Ahmad Ghorab

ORCID

, Elias J. Jabbour, Issa Ghayas, Koji Sasaki, Tapan Kadia, Zeev Estrov

Pattern of mutational changes in patients with chronic phase CML who are treated with frontline TKI and transform to blast phase CML

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Ahmad Ghorab

ORCID

, Hagop M. Kantarjian, Hesham Elhalawani, Hoda Ahmed, Ahmed Essam, Omar Abdel-Rahman, Elias J. Jabbour, Jorge E. Cortes

Comparative risk assessment of imatinib, nilotinib and dasatinib in randomized controlled trials: a meta-analysis

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Ahmad Ghorab

ORCID

, Preetesh Jain, Hagop M. Kantarjian, Rashmi Kanagal-Shamanna, Elias J. Jabbour, Koji Sasaki, Tapan Kadia, Guillermo Garcia-Manero, Prithviraj Bose, Musa Yilmaz

Isolated Extramedullary (EMD) Blastic Transformation of Chronic Myeloid Leukemia (CML-BP) in the TKI Era: Characteristics, Treatments and Outcomes

Upload

Missing publications? Search for publications with a matching author name.